Intrinsic value of Hepion Pharmaceuticals, Inc. (HEPA)
Live fair value data for Hepion Pharmaceuticals, Inc. (HEPA) is currently unavailable. Please check again shortly.
Current Price: $446.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Hepion Pharmaceuticals, Inc. (HEPA) undervalued or overvalued?
Based on the current model output, Hepion Pharmaceuticals, Inc. appears to be overvalued with a downside of 1.00%.
Fair value vs market price — Hepion Pharmaceuticals, Inc. (HEPA)
Unlock premium access to view the live fair value comparison against current market price for HEPA.
Frequently Asked Questions - HEPA
How is HEPA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for HEPA.
Is HEPA undervalued or overvalued right now?
HEPA is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for HEPA: open their intrinsic value pages.